Brachytherapy is a form of internal radiation therapy often recommended to individuals undergoing treatment for endometrial cancer. This type of treatment involves the insertion of radioactive material into the body to target and destroy cancer cells. According to the American Cancer Society (ACS), brachytherapy is frequently used following surgery to remove the uterus and cervix.
There are two main types of brachytherapy used in the treatment of endometrial cancer – low dose rate (LDR) and high dose rate (HDR) brachytherapy. LDR brachytherapy involves delivering lower doses of radiation over a longer period, typically lasting between 1 to 4 days. On the other hand, HDR brachytherapy administers a higher dose over a shorter timeframe, usually around 10 to 20 minutes. The choice between LDR and HDR depends on the individual case and the recommendations of the healthcare provider.
One of the risks associated with LDR brachytherapy is deep vein thrombosis due to limited mobility during treatment. Additionally, radiation vaginitis and low blood counts leading to anemia and fatigue are common side effects of brachytherapy. Vaginal dryness, vaginal scar tissue, and radiation cystitis are some long-term side effects that individuals may experience after treatment. It is essential for patients to communicate any discomfort or side effects to their healthcare provider for appropriate management.
Recovery from brachytherapy can vary from person to person, with most side effects resolving within a few weeks to a couple of months after treatment. While fatigue may persist for some time, other side effects may linger for longer periods. Some individuals may experience long-term side effects months or even years after treatment. It is crucial to stay in close communication with healthcare providers to address any concerns or new symptoms that may arise.
Besides brachytherapy, individuals with endometrial cancer may undergo other treatment modalities such as external beam radiation, surgery, chemotherapy, or hormone therapy, depending on the stage and characteristics of the cancer. Progestin therapy, clinical trials, or immunotherapy may be considered in specific cases. Careful consideration of various factors, including the individual’s overall health, age, and treatment goals, is essential in determining the most suitable treatment plan.
Brachytherapy remains a valuable treatment option in the comprehensive management of endometrial cancer. While it effectively targets cancer cells, it also carries inherent risks and potential side effects that individuals need to be aware of. Close monitoring, open communication with healthcare providers, and understanding the recovery process are vital aspects of navigating through brachytherapy treatment. By staying informed and actively participating in the decision-making process, individuals can optimize their treatment outcomes and overall well-being.
Leave a Reply